Regulation of p21 by TWIST2 contributes to its tumor-suppressor function in human acute myeloid leukemia (original) (raw)

• Thisse B, Stoetzel C, Gorostiza-Thisse C, Perrin-Schmitt F . Sequence of the twist gene and nuclear localization of its protein in endomesodermal cells of early Drosophila embryos. EMBO J 1988; 7: 2175–2183.
  Article CAS PubMed PubMed Central Google Scholar
• Franco HL, Casasnovas J, Rodríguez-Medina JR, Cadilla CL . Redundant or separate entities?-roles of Twist1 and Twist2 as molecular switches during gene transcription. Nucleic Acids Res 2011; 39: 1177–1186.
  Article CAS PubMed Google Scholar
• Sandmann T, Girardot C, Brehme M, Tongprasit W, Stolc V, Furlong EE . A core transcriptional network for early mesoderm development in Drosophila melanogaster. Genes Dev 2007; 21: 436–449.
  Article CAS PubMed PubMed Central Google Scholar
• Spicer DB, Rhee J, Cheung WL, Lassar AB . Inhibition of myogenic bHLH and MEF2 transcription factors by the bHLH protein Twist. Science 1996; 272: 1476–1480.
  Article CAS PubMed Google Scholar
• Gong XQ, Li L . Dermo-1, a multifunctional basic helix-loop-helix protein, represses MyoD transactivation via the HLH domain, MEF2 interaction, and chromatin deacetylation. J Biol Chem 2002; 277: 12310–12317.
  Article CAS PubMed Google Scholar
• Bialek P, Kern B, Yang X, Schrock M, Sosic D, Hong N et al. A twist code determines the onset of osteoblast differentiation. Dev Cell 2004; 6: 423–435.
  Article CAS PubMed Google Scholar
• Isenmann S, Arthur A, Zannettino AC, Turner JL, Shi S, Glackin CA et al. TWIST family of basic helix-loop-helix transcription factors mediate human mesenchymal stem cell growth and commitment. Stem Cells 2009; 27: 2457–2468.
  Article CAS PubMed Google Scholar
• Yang DC, Yang MH, Tsai CC, Huang TF, Chen YH, Hung SC . Hypoxia inhibits osteogenesis in human mesenchymal stem cells through direct regulation of RUNX2 by TWIST. PLoS ONE 2011; 6: e23965.
  Article CAS PubMed PubMed Central Google Scholar
• Maestro R, Dei Tos AP, Hamamori Y, Krasnokutsky S, Sartorelli V, Kedes L et al. Twist is a potential oncogene that inhibits apoptosis. Genes Dev 1999; 13: 2207–2217.
  Article CAS PubMed PubMed Central Google Scholar
• Kalluri R, Weinberg RA . The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119: 1420–1428.
  Article CAS PubMed PubMed Central Google Scholar
• Ansieau S, Morel AP, Hinkal G, Bastid J, Puisieux A . TWISTing an embryonic transcription factor into an oncoprotein. Oncogene 2010; 29: 3173–3184.
  Article CAS PubMed Google Scholar
• Qin Q, Xu Y, He T, Qin C, Xu J . Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms. Cell Res 2012; 22: 90–106.
  Article CAS PubMed Google Scholar
• Ansieau S, Bastid J, Doreau A, Morel AP, Bouchet BP, Thomas C et al. Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell 2008; 14: 79–89.
  Article CAS PubMed Google Scholar
• Cakouros D, Isenmann S, Cooper L, Zannettino A, Anderson P, Glackin C et al. Twist-1 induces Ezh2 recruitment regulating histone methylation along the Ink4A/Arf locus in mesenchymal stem cells. Mol Cell Biol 2012; 32: 1433–1441.
  Article CAS PubMed PubMed Central Google Scholar
• Fang X, Cai Y, Liu J, Wang Z, Wu Q, Zhang Z et al. Twist2 contributes to breast cancer progression by promoting an epithelial-mesenchymal transition and cancer stem-like cell self-renewal. Oncogene 2011; 30: 4707–4720.
  Article CAS PubMed Google Scholar
• Ishikawa T, Shimizu T, Ueki A, Yamaguchi SI, Onishi N, Sugihara E et al. Twist2 functions as a tumor suppressor in murine osteosarcoma cells. Cancer Sci 2013; 104: 880–888.
  Article CAS PubMed PubMed Central Google Scholar
• Thathia SH, Ferguson S, Gautrey HE, van Otterdijk SD, Hili M, Rand V et al. Epigenetic inactivation of TWIST2 in acute lymphoblastic leukemia modulates proliferation, cell survival and chemosensitivity. Haematologica 2012; 97: 371–378.
  Article CAS PubMed PubMed Central Google Scholar
• Sharabi AB, Aldrich M, Sosic D, Olson EN, Friedman AD, Lee SH et al. Twist-2 controls myeloid lineage development and function. PLoS Biol 2008; 6: e316.
  Article PubMed PubMed Central Google Scholar
• Raval A, Lucas DM, Matkovic JJ, Bennett KL, Liyanarachchi S, Young DC et al. TWIST2 demonstrates differential methylation in immunoglobulin variable heavy chain mutated and unmutated chronic lymphocytic leukemia. J Clin Oncol 2005; 23: 3877–3885.
  Article CAS PubMed Google Scholar
• Šošić D, Richardson JA, Yu K, Ornitz DM, Olson EN . Twist regulates cytokine gene expression through a negative feedback loop that represses NF-kappaB activity. Cell 2003; 112: 169–180.
  Article PubMed Google Scholar
• Shiota M, Izumi H, Onitsuka T, Miyamoto N, Kashiwagi E, Kidani A et al. Twist and p53 reciprocally regulate target genes via direct interaction. Oncogene 2008; 27: 5543–5553.
  Article CAS PubMed Google Scholar
• Piccinin S, Tonin E, Sessa S, Demontis S, Rossi S, Pecciarini L et al. A ‘twist box’ code of p53 inactivation: twist box: p53 interaction promotes p53 degradation. Cancer Cell 2012; 22: 404–415.
  Article CAS PubMed Google Scholar
• Cheng GZ, Chan J, Wang Q, Zhang W, Sun CD, Wang LH . Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. Cancer Res 2007; 67: 1979–1987.
  Article CAS PubMed Google Scholar
• Shiota M, Izumi H, Onitsuka T, Miyamoto N, Kashiwagi E, Kidani A et al. Twist promotes tumor cell growth through YB-1 expression. Cancer Res 2008; 68: 98–105.
  Article CAS PubMed Google Scholar
• Yang MH, Hsu DS, Wang HW, Wang HJ, Lan HY, Yang WH et al. Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition. Nat Cell Biol 2010; 12: 982–992.
  Article PubMed Google Scholar
• Hao Y, Crenshaw T, Moulton T, Newcomb E, Tycko B . Tumour-suppressor activity of H19 RNA. Nature 1993; 365: 764–767.
  Article CAS PubMed Google Scholar
• Duriez C, Falette N, Audoynaud C, Moyret-Lalle C, Bensaad K, Courtois S et al. The human BTG2/TIS21/PC3 gene: genomic structure, transcriptional regulation and evaluation as a candidate tumor suppressor gene. Gene 2002; 282: 207–214.
  Article CAS PubMed Google Scholar
• Sakamuro D, Elliott KJ, Wechsler-Reya R, Prendergast GC . BIN1 is a novel MYC-interacting protein with features of a tumour suppressor. Nat Genet 1996; 14: 69–77.
  Article CAS PubMed Google Scholar
• Kennah E, Ringrose A, Zhou LL, Esmailzadeh S, Qian H, Su MW et al. Identification of tyrosine kinase, HCK, and tumor suppressor, BIN1, as potential mediators of AHI-1 oncogene in primary and transformed CTCL cells. Blood 2009; 113: 4646–4655.
  Article CAS PubMed Google Scholar
• Narla G, Heath KE, Reeves HL, Li D, Giono LE, Kimmelman AC et al. KLF6, a candidate tumor suppressor gene mutated in prostate cancer. Science 2001; 294: 2563–2566.
  Article CAS PubMed Google Scholar
• Ueda K, Arakawa H, Nakamura Y . Dual-sepecificity phosphatase 5 (DUSP5) as a direct transcriptional target of tumor suppressor p53. Oncogene 2003; 22: 5586–5591.
  Article CAS PubMed Google Scholar
• Kawagoe H, Kandilci A, Kranenburg TA, Grosveld GC . Overexpression of N-Myc rapidly causes acute myeloid leukemia in mice. Cancer Res 2007; 67: 10677–10685.
  Article CAS PubMed Google Scholar
• Nagel S, Burek C, Venturini L, Scherr M, Quentmeier H, Meyer C et al. Comprehensive analysis of homeobox genes in Hodgkin lymphoma cell lines identifies dysregulated expression of HOXB9 mediated via ERK5 signaling and BMI1. Blood 2007; 109: 3015–3023.
  CAS PubMed Google Scholar
• Yin B, Delwel R, Valk PJ, Wallace MR, Loh ML, Shannon KM et al. A retroviral mutagenesis screen reveals strong cooperation between Bcl11a overexpression and loss of the Nf1 tumor suppressor gene. Blood 2009; 113: 1075–1085.
  Article CAS PubMed PubMed Central Google Scholar
• Eppert K, Takenaka K, Lechman ER, Waldron L, Nilsson B, van Galen P et al. Stem cell gene expression programs influence clinical outcome in human leukemia. Nat Med 2011; 17: 1086–1093.
  Article CAS PubMed Google Scholar
• Liu JH, Yen CC, Lin YC, Gau JP, Yang MH, Chao TC et al. Overexpression of cyclin D1 in accelerated-phase chronic myeloid leukemia. Leuk Lymphoma 2004; 45: 2419–2425.
  Article CAS PubMed Google Scholar
• Wang M, Sun L, Qian J, Han X, Zhang L, Lin P et al. Cyclin D1 as a universally expressed mantle cell lymphoma-associated tumor antigen for immunotherapy. Leukemia 2009; 23: 1320–1328.
  Article CAS PubMed PubMed Central Google Scholar
• Shivdasani RA, Mayer EL, Orkin SH . Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL. Nature 1995; 373: 432–434.
  Article CAS PubMed Google Scholar
• Capron C, Lécluse Y, Kaushik AL, Foudi A, Lacout C, Sekkai D et al. The SCL relative LYL-1 is required for fetal and adult hematopoietic stem cell function and B-cell differentiation. Blood 2006; 107: 4678–4686.
  Article CAS PubMed Google Scholar
• Kee BL . E and ID proteins branch out. Nat Rev Immunol 2009; 9: 175–184.
  Article CAS PubMed Google Scholar
• Souroullas GP, Salmon JM, Sablitzky F, Curtis DJ, Goodell MA . Adult hematopoietic stem and progenitor cells require either Lyl1 or Scl for survival. Cell Stem Cell 2009; 4: 180–186.
  Article CAS PubMed PubMed Central Google Scholar
• Aplan PD, Lombardi DP, Reaman GH, Sather HN, Hammond GD, Kirsch IR . Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukemia. Blood 1992; 79: 1327–1333.
  CAS PubMed Google Scholar
• Meng YS, Khoury H, Dick JE, Minden MD . Oncogenic potential of the transcription factor LYL1 in acute myeloblastic leukemia. Leukemia 2005; 19: 1941–1947.
  Article CAS PubMed Google Scholar
• Ko J, Patel N, Ikawa T, Kawamoto H, Frank O, Rivera RR et al. Suppression of E-protein activity interferes with the development of BCR-ABL-mediated myeloproliferative disease. Proc Natl Acad Sci USA 2008; 105: 12967–12972.
  Article CAS PubMed PubMed Central Google Scholar
• Sharif MN, Sosic D, Rothlin CV, Kelly E, Lemke G, Olson EN et al. Twist mediates suppression of inflammation by type I IFNs and Axl. J Exp Med 2006; 203: 1891–1901.
  Article CAS PubMed PubMed Central Google Scholar
• Cosset E, Hamdan G, Jeanpierre S, Voeltzel T, Sagorny K, Hayette S et al. Deregulation of TWIST-1 in the CD34+ compartment represents a novel prognostic factor in chronic myeloid leukemia. Blood 2011; 117: 1673–1676.
  Article CAS PubMed Google Scholar
• Li X, Marcondes AM, Gooley TA, Deeg HJ . The helix-loop-helix transcription factor TWIST is dysregulated in myelodysplastic syndromes. Blood 2010; 116: 2304–2314.
  Article CAS PubMed PubMed Central Google Scholar
• Li X, Xu F, Chang C, Byon J, Papayannopoulou T, Deeg HJ et al. Transcriptional regulation of miR-10a/b by TWIST-1 in myelodysplastic syndromes. Haematologica 2013; 98: 414–419.
  Article CAS PubMed PubMed Central Google Scholar
• Kim MS, Kim GM, Choi YJ, Kim HJ, Kim YJ, Jin W TrkC promotes survival and growth of leukemia cells through Akt-mTOR-Dependent Up-Regulation of PLK-1 and Twist-1. Mol Cells 2013; 36: 177–184.
  Article CAS PubMed PubMed Central Google Scholar
• el Ghouzzi V, Le Merrer M, Perrin-Schmitt F, Lajeunie E, Benit P, Renier D et al. Mutations of the TWIST gene in the Saethre-Chotzen syndrome. Nat Genet 1997; 15: 42–46.
  Article CAS PubMed Google Scholar
• Howard TD, Paznekas WA, Green ED, Chiang LC, Ma N, Ortiz de Luna RI et al. Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome. Nat Genet 1997; 15: 36–41.
  Article PubMed Google Scholar
• Tukel T, Šošić D, Al-Gazali LI, Erazo M, Casasnovas J, Franco HL et al. Homozygous nonsense mutations in TWIST2 cause Setleis syndrome. Am J Hum Genet 2010; 87: 289–296.
  Article CAS PubMed PubMed Central Google Scholar
• Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545–15550.
  Article CAS PubMed PubMed Central Google Scholar
• Liberzon A, Subramanian A, Pinchback R, Thorvaldsdóttir H, Tamayo P, Mesirov JP . Molecular signatures database (MSigDB) 3.0. Bioinformatics 2011; 27: 1739–1740.
  Article CAS PubMed PubMed Central Google Scholar
• Zhou H, Ge Y, Sun L, Ma W, Wu J, Zhang X et al. Growth arrest specific 2 is up-regulated in chronic myeloid leukemia cells and required for their growth. PLoS ONE 2014; 9: e86195.
  Article PubMed PubMed Central Google Scholar
• Zhang W, Liu J, Tabata Y, Meng J, Xu H . The effect of serum in culture on RNAi efficacy through modulation of polyplexes size. Biomaterials 2014; 35: 567–577.
  Article CAS PubMed Google Scholar
• Zhang W, Gao Y, Li P, Shi Z, Guo T, Li F et al. VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex. Cell Res 2014; 24: 331–343.
  Article CAS PubMed PubMed Central Google Scholar